chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Follow-up information received 15-AUG-2003 provided medical history, event onset date, treatment medications, and outcome. A physician reported that a 44-year-old female received an injection of influenza virus vaccine (manufacturer unknown) on 16-NOV-1994. The patient's medical history included an allergy to cats, hypertension, migraine headaches, and low thyroid. That same day, she was seen in the ER for an anaphylactic reaction characterized by generalized erythema, pruritis, throat tightness, and SOB. She was treated with SC epinephrine, IV and oral Benadryl (diphenhydramine), physician reported that the pt ate chicken and potatoes 1-2 hours prior to onset of symptoms. This event was considered medically important (OMIC).
Pt. noted onset of "numbness", heat and heaviness over her left facial cheek area with a 5X4 inch area. She denied any difficulty swallowing, no trouble breathing, no associated symptoms, no motor impairments of cranial nerves
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of unknown age and gender. No information was provided regarding concomitant medications, concurrent conditions or medical history. On or about 2016, the patient was vaccinated with a dose of ZOSTAVAX (lot #, expiration date, dose, route and site of administration were not reported) to obtain permanent prevention and protection against shingles and zoster-related injuries. In 2016, after and despite being inoculated with the ZOSTAVAX, the patient was diagnosed with shingles and/or other zoster-related injuries and suffered serious physical, emotional and economic damages as a result of patient's injuries. On or about 11-OCT-2016, the patient was treated for shingles. The reporter considered adverse events to be related to ZOSTAVAX. As a direct and proximate result of the ZOSTAVAX, the patient had and would continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care - for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. By the time of the report, the patient did not recover from shingles as the patient suffer for ongoing injuries. The outcome of vaccination failure was unknown. The events were considered to be related to ZOSTAVAX.
6 hrs after the injection fever, chills severe malaise prompted. No chest or GI or GU symptoms. Duration days.
his blood pressure is too high / his blood pressure spiked up; loss of sense of taste and smell; loss of sense of taste and smell; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date May2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. Relevant medical history included: "lost taste and smell" (unspecified if ongoing), notes: nearly a year and a half ago, then it back at 5% at the most; "lost taste and smell" (unspecified if ongoing), notes: he also lost taste and smell, that was nearly a year and a half ago, then after this it came out and his sense of taste and smell was back at 5% at the most. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (1st dose was last April, Dates for Pfizer COVID-19 vaccine: (Start: Apr2021 Stop: Unspecified)), administration date: Apr2021, for COVID-19 immunisation. The following information was reported: HYPERTENSION (non-serious) with onset 2021, outcome "unknown", described as "his blood pressure is too high / his blood pressure spiked up"; AGEUSIA (non-serious), ANOSMIA (non-serious) all with onset 2021, outcome "unknown" and all described as "loss of sense of taste and smell". Relevant laboratory tests and procedures are available in the appropriate section. Additional information: The patient reported his age to be above 50 and he could not receive booster dose as his blood pressure was too high. He said he also lost taste and smell, that was nearly a year and a half ago, then after this it came out and his sense of taste and smell was back at 5% at the most. He says there was a chance he had COVID to lose sense of taste and smell, for it to come back, but he was tested 6 times with negatives. He got the Pfizer COVID-19 vaccine back in April, then got his second in May. He said his blood pressure had been getting worse, he wondered if getting the booster shot had to do with it. He said if he had COVID-19 it could have had to do with it, but he had bad health and wouldn't have known it. He said his blood pressure has gotten lower, it is 94-95 most of the time.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
6/28/13 Received TDAP shot next day in LA redness, swelling office visit 7/5/13 developed cellulitis.
a day after covid pfizer vaccination, patient started experiencing a cough that she has never had before as well as a runny nose. it is still there at her 2nd dose appointment
This 71  year old  female received the Covid shot on 2/27 /21    and went to the ED on 3/3 /21     and was admitted  on 3/4/21 with the following diagnoses listed below. R56.9 - Unspecified convulsions
Fever of 99.9 and body wide aches by 12 pm, ongoing until about 2 hours later after I took 2 ibuprofen at 1p. Night before I also had aches, but not fever, and took 2 Tylenol, but they did not help.
PV 13 8-19-16. Redness and swelling at site (L) delt.
No adverse event; Patient inadvertently administered bivalent vaccine as first dose instead of the monovalent vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (Patient inadvertently administered bivalent vaccine as first dose instead of the monovalent vaccine) and NO ADVERSE EVENT (No adverse event) in a 23-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Oct-2022, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .5 milliliter. On 10-Oct-2022, the patient experienced WRONG PRODUCT ADMINISTERED (Patient inadvertently administered bivalent vaccine as first dose instead of the monovalent vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Patient inadvertently administered bivalent vaccine as first dose instead of the monovalent vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Patient inadvertently administered bivalent vaccine as first dose instead of the monovalent vaccine).    No concomitant medications were reported.  No treatment medications were reported.
diarrhea; patient experiencing panic attack in the past but believe this is attributed to existing anxiety issue, believe some of these happened after vaccination; This is a spontaneous report received from a contactable reporter(s) (Other HCP).  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Auto immune disease" (unspecified if ongoing); "Panic attack" (unspecified if ongoing), notes: Patient experiencing panic attack in the past; "Allergy to grass" (unspecified if ongoing), notes: May have an allergy to grass but not 100% sure. The patient's concomitant medications were not reported. The following information was reported: DIARRHOEA (non-serious), outcome "unknown", described as "diarrhea"; PANIC ATTACK (non-serious), outcome "unknown", described as "patient experiencing panic attack in the past but believe this is attributed to existing anxiety issue, believe some of these happened after vaccination".  Additional information: As a note as well, sometime in Apr/May/Jun the patient believe of 2021, had started using anxiety medication that had to switch away from (to a different medication) since was giving a side effect of diarrhea, the event onset date should be May or June. As a note, there have been reports of experiencing panic attack in the past but believe this is attributed to existing anxiety issue. There has been at least one time where has experienced them more than usual in a time period (believe was under stress when occurred).   The lot number for bnt162b2 was not provided and will be requested during follow up.
Immediately after I got a rush from the top of my head to my toes. My whole body went tingly. I felt light headed and numb. I felt nauseous and out of it. I had shivers. My throat felt like it was swelling whenever I tried to take a drink or eat anything to feel better. I had to be monitored for over an hour and then driven home. I was too dizzy to walk.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of unknown gender and age. No information was provided regarding concomitant medications, concurrent conditions or medical history. On or about an unknown date in 2015 or 2016, the patient was inoculated with ZOSTAVAX by a healthcare provider as recommended for permanent prevention and protection against shingles and zoster related conditions (dose, route, and lot # not provided). On an unknown date, the patient was diagnosed with shingles and/or zoster related injuries after and despite being inoculated with ZOSTAVAX vaccine and suffered serious mental and physical pain and suffering and required extensive medical care and treatment. On or about 25-JAN-2017, the patient was treated by a healthcare provider for shingles. As a further proximate result, the patient had suffered and would continue to suffer significant medical expenses, and pain and suffering, and other medical related expenses which includes but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was unknown. Causality assessment was related.
Myalgia, Arthralgia, Diarrhea, NauseaVomiting, Lymphadenopathy clavicular & ipsilateral axillary. Fatigue. Light headed Narrative:  This time light headed & nausea started almost immediately. Night of 1/7 kept waking up because left side was hurting. (left deltoid injection). Friday Tylenol - localized Friday night. Some lymph node swelling at clavicle & axilla & inguinal - painful. Called in sick. Saturday Sunday Fatigue, muscle pain & stomach cramps. Loose bowels. Chills/Sweats Not febrile. Arm still tender.
Patient got all three of the vaccines and within the next 4 days patient was not feeling well they were short of breath and were having a low heart rate. Patient was taken and admitted into the hospital for 12 to 13 days. Patient was also feeling weak. Patient is still in the hospital and the patient can't return home and is instead going to a nursing home  so the patient can help recover.
Patient reports dizziness, vomiting, very swollen left arm, went to hospital ER and was treated but she doesn't know with what.
Patient appeared to have vaso-vagal response several minutes after administration of vaccine.  Supportive care given until ems arrived.
Dose 1 given 1/4/2021-Lot # N/A Patient died at hospital on 12/12/2021 - failure to thrive. He did not have Covid 19.
pt brought to ER 145AM w/convulsions & vomiting & t102-103;tachycardic
(1) patient was lightheaded immediately after vaccination (2) patient's eyes rolled back was unconscious for approx. 1 minute about 30 minutes after (3) paramedics were called and attended to her and took her to the hospital
flu like symptoms; cold; pain in arm; stomach upset; depression and anxiety symptoms have worsened since receiving 1st dose of Moderna COVID 19; depression and anxiety symptoms have worsened since receiving 1st dose of Moderna COVID 19; has no strength; sleeping a lot; lower back is in pain; crying a lot; feel like I can not function, haven't showered since 19Apr2021; "I am very short, yelling and screaming, wasn't like this before"; nausea; fever; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms), NASOPHARYNGITIS (cold), PAIN IN EXTREMITY (pain in arm), ABDOMINAL DISCOMFORT (stomach upset) and DEPRESSION (depression and anxiety symptoms have worsened since receiving 1st dose of Moderna COVID 19) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001CZ1A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Tooth infection (Mouth infection from 09 Mar 2021 to 14 Apr 2021-four cycles of antibiotics and pain killers) on 09-Mar-2021. Concurrent medical conditions included Depression and Anxiety.    On 18-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Apr-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms), NASOPHARYNGITIS (cold), PAIN IN EXTREMITY (pain in arm), ABDOMINAL DISCOMFORT (stomach upset), DEPRESSION (depression and anxiety symptoms have worsened since receiving 1st dose of Moderna COVID 19), ANXIETY (depression and anxiety symptoms have worsened since receiving 1st dose of Moderna COVID 19), ASTHENIA (has no strength), SOMNOLENCE (sleeping a lot), BACK PAIN (lower back is in pain), CRYING (crying a lot), FEELING ABNORMAL (feel like I can not function, haven't showered since 19Apr2021), ANGER ("I am very short, yelling and screaming, wasn't like this before"), NAUSEA (nausea) and PYREXIA (fever). The patient was treated with IBUPROFEN at an unspecified dose and frequency. On 19-Apr-2021, FEELING ABNORMAL (feel like I can not function, haven't showered since 19Apr2021) had resolved. On 22-Apr-2021, INFLUENZA LIKE ILLNESS (flu like symptoms), NASOPHARYNGITIS (cold), PAIN IN EXTREMITY (pain in arm), ABDOMINAL DISCOMFORT (stomach upset), NAUSEA (nausea) and PYREXIA (fever) had resolved. At the time of the report, DEPRESSION (depression and anxiety symptoms have worsened since receiving 1st dose of Moderna COVID 19), ANXIETY (depression and anxiety symptoms have worsened since receiving 1st dose of Moderna COVID 19), ASTHENIA (has no strength), SOMNOLENCE (sleeping a lot), BACK PAIN (lower back is in pain), CRYING (crying a lot) and ANGER ("I am very short, yelling and screaming, wasn't like this before") outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not provided.
About five minutes after I received the shot, I started feeling  faint. I also felt like my nasal passages, throat, and bronchial tube were swelling up .  Taking a decongestant helped that.    For a couple days following the shot, I had brain fog.
felt so sick; she felt horrible; weak; had stayed in bed; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (felt so sick), FEELING ABNORMAL (she felt horrible), ASTHENIA (weak) and SOMNOLENCE (had stayed in bed) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (felt so sick), FEELING ABNORMAL (she felt horrible), ASTHENIA (weak) and SOMNOLENCE (had stayed in bed). At the time of the report, ILLNESS (felt so sick), FEELING ABNORMAL (she felt horrible) and ASTHENIA (weak) had resolved and SOMNOLENCE (had stayed in bed) had not resolved.            No concomitant medications were reported. No treatment medications were reported.   This case was linked to MOD-2021-051748, MOD-2021-051748 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 27-Jul-2021: Patient's email address was updated.
One day following the Covid vaccine [second dose in two part series], slight loss of smell has presented. The loss if smell in particular was noted related to a daily fermented grain that usually displays a sour fermented smell. Though said patient could not smell the sour odor, another household member could smell it [said household member was also vaccinated with the second Pfiezer Covid vaccine dose the same day].  Reporting patient maintains other normal sense of smell and taste thus far.
Received an incorrectly stored vaccine; A spontaneous report was received from a consumer concerning a 73-year-old, male patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and reported receiving  an incorrectly stored vaccine.  The patient's medical history, was not reported. Concomitant medications was not reported.   On 01 Mar 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: 025A21A)for prophylaxis of COVID-19 infection.   On 01 Mar 2021, the patient was informed by the vaccination provider that his vaccine was stored incorrectly.  No laboratory details was provided.No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the event, receiving  an incorrectly stored vaccine , was considered resolved .; Reporter's Comments: This report refers to a case of Incorrectly stored vaccine for mRNA-1273, lot # 025A21A with no associated AEs.
acute onset right sided facial palsy. presented to emergency department diagnosed with Bell's palsy treated with valacyclovir and prednisone
Injection site reaction with edema, eythema that advanced outward from the site, and induration that lasted until 1/7/2021. Site assessed by MD who sited need for reporting.  Reaction largely resolved today 1/8/2021 apart from minor redness and edema.
Headache and dizziness on 26MAR21.  Taking tynenol on 27MAR21 and 28MAR21.  Loss of balance on 29MAR21.  Drooping face and slurred speech on 30MAR21.  Sent to emergency room the evening of 30MAR21.
After I got the vaccine, I started feeling warm and it felt like needle pricks in my muscles. Body was painful. I lost my appetite  but wasn't vomiting or having nausea. I had a migraine and fever and body aches and chills (I was either freezing or hot) - couldn't get warm enough - these symptoms I noticed about midnight - it woke me up after a couple hours of sleep and then I couldn't sleep. These symptoms lasted through to Monday. Tuesday, I wasn't feeling fantastic but I went back to work. Fever broke on Sunday morning. Migraine lasted five days. I took Tylenol for fever and ibuprofen for other symptoms. I had a virtual Dr appt on Friday, the 8th. I took migraine medicine but it wasn't really helping. I met again with Dr on 11th - virtual. I chose to go back work even though I wasn't better - felt fatigue and the headache on and off for a couple of weeks. Just since the beginning of February do I feel like fatigue has gone away.  When I work out, I do still notice that I get tired faster.
I received a quad flu shot in my left arm.  The arm was sore and hurt when I moved it for about a day.  A few days later, somewhere around the 19th, my upper arm became sore again and hurt to move.  I thought it was because I had slept on it wrong, but it has been three weeks and my arm is still sore.  I have been taking OTC naproxen when the pain and soreness becomes too much for daily activities.
Cellulitis - red, radiating heat, hard, inflamed, itchy deltoid; spread throughout entire upper arm, spread distal to forearm.
Pain at T-dap injection site, warm and tender to touch, erythematous and afebrile.  Treated with Keflex.
Temperature 104 degrees F, pain 8-10 out of 10, entire body weakness, dizzy, rapid heartbeat, swollen throat, harsh voice, trouble breathing, blur vision, yeast infection, nervousness, weight loss (rapid).
The upper left arm  and shoulder was swollen, hot, lumpy and sore. Patient reported that she had the same reactions last year whe she got the flu shot
Note: Any requests for follow-up information on this case should be sent directly to the sponsor of this study, Sanofi Pasteur. This study case was received from the investigator in a trial on 26 November 2013 with additional information received on 02 December 2013. A 22 year-old male subject with no significant past medical history was found to have unspecified acute pericarditis and acute idiopathic pericarditis 14 and 10 days respectively after the subject had received the following vaccines on 18 September 2013: an injection of ACAM2000 (lot number, route and site of administration not reported), TYPHIM VI (lot number, route and site of administration not reported) and Anthrax 1 (manufacturer, lot number and site of administration not reported). On 28 September 2013, the subject was found to have an abnormal ECG and a normal echocardiogram. On 29 September 2013, Troponin I result was abnormal with highest record value of 07.00 ng/ml. Lumbar puncture and MRI of the brain, spinal cord and heart were not performed. Treatments were not reported. The subject's outcome was not reported. Note: There is no reporter causality assessment as this is a safety surveillance (data mining, non-interventional) study. Documents held by sender: none.
Case number PHEH2016US023402 is an initial spontaneous report received from a nurse on 13 Sep 2016. This report refers to a 74 year old patient whose gender was not specified. The patient's medical history and concomitant medications were not reported. The patient was vaccinated with FLUVIRIN (batch number: 1515701) at a dose of 0.5 ml intramuscularly in the left arm on 20 Jan 2016. It was reported that the patient received FLUVIRIN multi dose vial (MDV) that had been exposed to 8 to 10 temperature excursion. The patient did not experience an adverse events following vaccination.
pt recvd vax; c/o discomfort of rt arm (throbbing, burning, aching) which began approx 1 wk following vax;reported to school RN 28nov94;refered to MD that day who advised to use warm packs PRN;may take apap/asa for discomfort;
At first, my nose hairs were itchy, then I got runny nose. I sprayed Flonase, which didn't seem to help that much except to dry out my nasal passage. Then, I started feeling lightheaded in the same evening and somewhat disconnected from my body. Then, the next morning, and all day, I've been clumsy and uncoordinated.
I got the shot that day and around 2:00am I woke up with very bad stomach pain and felt like I had the flu and was fighting diarrhea and had a migraine on the side of my head. I stayed balled up all day. Anything I ate would make my stomach hurt for hours so I ended up making me a doctors appointment and I asked my doctor and he didn't have a  answer.